Inositol triphosphate, cyclic AMP, and cyclic GMP in rat brain regions after lithium and seizures☆
References (31)
- et al.
Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex
Eur J Pharmacol
(1987) - et al.
Long term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain
Biol Psychiatry
(1989) - et al.
Effects of chronic lithium treatment on protein kinase C and cyclic AMP dependent protein phosphorylation
Biol Psychiatry
(1991) - et al.
Alteration of inositol phospholipid metabolism in rat cortex by lithium but not carbamazepine
Eur J Pharmacol
(1988) - et al.
Lithium modulation of cortical cyclic nucleotides: Evidence for the Yin-Yang hypothesis
Eur J Pharmacol
(1990) - et al.
Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo
Brain Res
(1987) - et al.
Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats
Exp Neurol
(1986) - et al.
Systemic lithium administration alters rat cerebral cortex phospholipids
Biol Psychiatry
(1987) - et al.
Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin
Eur J Pharmacol
(1986) - et al.
Effects of GTP on hormone stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium
Biol Psychiatry
(1989)
Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: Comparison with kainic acid
Exp Neurol
Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat
Neuropharmacology
Lithium but not cholinergic ligands influence guanylate cyclase activity in intact human lymphocytes
Biochem Pharmacol
Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex
Nature
Partial inhibition by lithium of the epinephrine-stimulated rise in plasma cyclic GMP in humans
Biol Psychiatry
Cited by (44)
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
2021, Biomedicine and PharmacotherapyCitation Excerpt :In this regard, lithium has diverse effects on inflammatory mediators, such as modulating the expression of several inflammatory genes including IκB-α, TRAF3, Tollip, and NF-κB1/p50, while it inhibits NF-κB activity by lowering nuclear translocation of NF-κB in LPS-activated macrophages [313]. Animal studies have also shown lithium to either decrease [314] or increase activity of the NO-cGMP pathway [315,316]. Recently, Pietruczuk et al. [167] demonstrated that T lymphocytes of patients suffering from bipolar disorder that were treated with lithium or valproate, are characterized by pro-inflammatory activity, decreased proliferative activity and increased susceptibility to apoptosis.
lazaro encodes a lipid phosphate phosphohydrolase that regulates phosphatidylinositol turnover during Drosophila phototransduction
2006, NeuronCitation Excerpt :PI is synthesized in the ER by the condensation of inositol and CDP-DAG by PI synthase. Previous studies have suggested the importance of a constant supply of inositol generated from IP3 to maintain ongoing G protein-coupled PLC signaling in neurons (Gani et al., 1993; Jope et al., 1992; Kendall and Nahorski, 1987; Kennedy et al., 1990). However, the role, if any, for the recycling of DAG to supply CDP-DAG required for PI synthesis has thus far not been addressed.
Effect of chronic lithium treatment on the turnover of α<inf>2</inf>- adrenoceptors after chemical inactivation in rats
2004, European NeuropsychopharmacologyLithium detaches hexokinase from mitochondria and inhibits proliferation of B16 melanoma cells
2003, Molecular Genetics and MetabolismLithium reduces tau phosphorylation: Effects in living cells and in neurons at therapeutic concentrations
1999, Biological PsychiatryEffects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat
1998, European Neuropsychopharmacology
- ☆
This work was supported by NIMH grant MH38752 and by the U.S. Army medical Research and Development Command under contract No. DAMD17-89-C-9037. Opinions, interpretations, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army. In conducting research using animals, the investigators adhered to the Guide for the Care and Use of Laboratory Animals prepared by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council.
- ∗
The authors thank Dot McAdory for manuscript preparation.